However, as shown previously, cyto-IL-15 exerts its anti-tumor effects approximately 14 days after treatment and samples in that study were collected at survival endpoint (~28 days post-treatment), whereas the tumors in the present study were collected only at 6 days post-treatment. This evidence concerns the gene IL15 and neoplasm.